HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Turns Up Heat On PFAS With Broad REACH Restriction Proposal In The Works

Executive Summary

Per- and polyfluoroalkyl substances (PFAS) are under increasing scrutiny in the US and Europe. Stakeholders have until 31 July to submit information to the authorities of five European countries as they prepare a joint proposal for a broad PFAS restriction under the bloc’s REACH regulation.

You may also be interested in...



EU Member States Propose Broad PFAS Restriction Under REACH

Per- and polyfluoroalkyl substances (PFAS) number in the thousands, and all are being targeted with a REACH restriction proposal submitted to the European Chemicals Agency by the national authorities of Denmark, Germany, the Netherlands, Norway and Sweden.

‘Green’ Beauty No Better Than Mainstream At Avoiding PFAS Contamination – Mamavation Study

Women’s wellness website and activist campaign Mamavation says its findings weren’t unexpected per se, “but we were surprised at the amount of contamination we discovered.” So why are mainstream and green beauty brands alike being contaminated with PFAS “forever chemicals”? 

California Bill Advances To Ban Cosmetic Ingredients Prohibited In EU, With PCPC’s Backing

The California Toxic-Free Cosmetics Act passed out of the State Assembly Committee on Environmental Safety and Toxic Materials on 14 May. A far cry from the original draft of the bill, AB 2762 would ban more than a dozen cosmetic ingredients in California whose use is prohibited already in Europe.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel